Hengrui Medicine (01276): SHR-1139 Injection approved for clinical trials.

Wisdom Finance APP News, Hengrui Medicine (01276) announced that recently, its subsidiary Guangdong Hengrui Medicine Co., Ltd. received the drug clinical trial approval notification issued by the National Medical Products Administration for SHR-1139 injection, and will soon start the clinical trial.